Previous 10 | Next 10 |
Schrodinger SDGR -25% on Q4 earnings release.Purple Innovation PRPL -21% on Q4 earning release.Qutoutiao QTT -20% on Q4 earning release.Yext YEXT -19% on Q4 earning release.Vroom VRM -15% on Q4 earning release.KemPharm (KMPH) -13%.Salarius Pha...
NEWTON, Mass., March 01, 2021 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today reported fi...
NEWTON, Mass., March 01, 2021 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today announced t...
NEWTON, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today announced to...
Acer to receive $1 million payment to obtain exclusivity and a $4 million loan from Relief Companies working toward negotiation and execution of a definitive collaboration and license agreement by June 30, 2021 GENEVA and NEWTON, Mass., Jan. 25, 2021 (GLOBE NEWSWIRE)...
Express (EXPR) +131%.TS Innovation Acquisitions (TSIA) +82% on merger agreement with Latch Inc..Aemetis (AMTX) +60%.Spartan Acquisition Corp. II (SPRQ) +51% on entering into business combination agreement with Sunlight.VYNE Therapeutics (VYNE) +40%.GameStop (GME) +43%.Aurinia Pharma...
Relief Therapeutics (RLFTF) and Acer Therapeutics (ACER) have signed an Option Agreement providing exclusivity for the right to negotiate a potential collaboration and license agreement for worldwide development and commercialization for ACER-001.ACER-001 (sodium phenylbutyrate) powder is a t...
Gainers: Obalon Therapeutics OBLN +181%, Caladrius Biosciences (CLBS) +137%, Titan Medical (TMDI) +36%, Tiziana Life Sciences (TLSA) +31%, Gritstone Oncology GRTS +12%.Losers: BioLineRx BLRX -24%, AcelRx Pharmaceuticals ACRX -17%,...
Acer Therapeutics (ACER) has announced full enrollment of 36 subjects in its pivotal trial evaluating the bioequivalence of ACER-001 vs. Horizon Therapeutics' Buphenyl (sodium phenylbutyrate) for the treatment of urea cycle disorders ((UCDs)). Results from the trial are expected in ...
NEWTON, Mass., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today announced fu...
News, Short Squeeze, Breakout and More Instantly...
Acer Therapeutics Inc. Company Name:
ACER Stock Symbol:
NASDAQ Market:
Acer Therapeutics Inc. Website:
AERWINS Technologies Inc. (AWIN) is expected to report for Q1 2024 Minera IRL Ltd ADR (MRLLY) is expected to report for quarter end 2023-09-30 SmileDirectClub, Inc. - Ordinary Shares - Class A (SDCCQ) is expected to report $-0.1 for Q3 2023 NextPlay Technologies Inc. (NXTP) is expecte...
INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...
Acer Therapeutics Inc. (ACER) is expected to report $-0.13 for Q3 2023